In the vote tally for the survey in #msg-24846668, there were five votes for “Some other company.” I’m wondering if any of these votes were for AZN/MedImmune. The reason I ask is that MedImmune is giving a 6-hour investor presentation today on its programs in biologics.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”